Eribulin Eg

Eribulin is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin is primarily used in the treatment of metastatic breast cancer. It may also be used for other types of cancer, as determined by a healthcare provider. The medication is administered intravenously and is designed to target and destroy cancer cells.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some individuals may experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. These effects vary and should be discussed with a healthcare provider.

Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow all safety guidelines when administering the medication. Pregnant women and individuals with certain medical conditions should consult a healthcare provider before use.

Eribulin may interact with other medications, including those that affect liver enzymes. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin.